For more details on our Mean More® Score, please download our thought paper.
Every spring, warming temperatures bring the landscape back to life after its winter dormancy. The season’s change ushers in the annual explosion of new life and, unfortunately for many Americans, an explosion of irritating seasonal allergies that makes breathing springtime air an unpleasant experience.
This seasonal change – and other factors like pet dander that cause runny nose, itchy and watery eyes, hives and other symptoms – sends many consumers to their local pharmacy to stock up on allergy medication. There are a lot of options for treating seasonal allergies, ranging in price, how they tackle symptoms, how they’re administered, and whether a prescription is required.
So, which allergy medicine leads in consumer preference? Meyocks’ proprietary Mean More® Score metric quantifies consumer disappointment with having to use the second choice in a given category. Meyocks research shows the majority of consumers would be most disappointed to give up their store brand over other widely known allergy medicine brands.
“A store brand” ranks highest with a score of 52 in our Mean More® Score survey, followed by Flonase®, Zyrtec®, Allegra® and Claritin®.
What makes store brands so popular? Price is obviously the key factor, as is the growing reputation of private brands for quality.
The result is a strong connection between the consumer and store brand allergy medications that yields the highest Mean More® Score in the product category.
Why do Mean More® Scores Matter?
A Meyocks analysis of a number of consumer categories shows that Mean More® Scores have a higher correlation with revenue growth than standard brand measurements like “Overall Brand Rating” and “Willingness to Recommend.”
Want to learn more about Mean More® Scores and what they can mean for your product category? Let’s talk.